默认字体 9pt 10pt 11pt 12pt 13pt 14pt 15pt 16pt 17pt 18pt 20pt 25pt  

FRAMINGHAM, Mass.—ARC/Architectural Resources Cambridge, a nationally-recognized architectural design firm specializing in the biotechnology, pharmaceutical industries and academic facilities with Bovis Lend Lease, a local and global leader in the construction management of life science facilities, today announced that Genzyme Corporation this week held a topping off ceremony for its new, innovative 177,000-square-foot science building located at 49 New York Avenue in Framingham, Massachusetts.

 

Designed by ARC and being constructed by Bovis Lend Lease, the new state-of-the-art laboratory and administrative office facility will be the signature building on Genzyme's Framingham campus.

 

Approximately 250 people attended the ceremony including business and community leaders, Genzyme, ARC and Bovis Lend Lease personnel, and members of the project's construction team. 

 

“Today's ceremony celebrated the placement of the last steel beam on the building, marking a significant milestone in the construction process,” said Henry S. Reeder, FAIA, a principal at ARC and lead architect for the project.  The building will be ready for occupancy in the third quarter of 2007.

 

Designed to accommodate a major portion of Genzyme's research activities, the new building will consolidate scientists located in a number of different locations, fulfilling a corporate objective to enhance the relationships between research groups. Each floor has been designed to promote collaboration and facilitate lab flexibility by locating a continuous band of laboratory bench space adjacent to the central support facilities.  In addition, the building is organized around a six-story atrium surrounded by casual meeting and lounge spaces to further encourage the spirit of interaction and teamwork.

 

The project also includes a separate 27,300-square-foot central utilities building that will supply the new Science Building, as well as the existing research, manufacturing and development buildings on the campus.

 

As part of this project, Genzyme is participating in the Laboratories of the 21 Century (Labs21) program, sponsored by the U.S. Environmental Protection Agency. The goal of the program is to improve the environmental performance of U.S. laboratories. The building's green features include a sophisticated heating and cooling system, high-efficiency fume hoods for researchers, low-flow water fixtures and landscaping based on drought-tolerant native species. The extensive use of glass was designed to maximize day lighting in conjunction with active artificial lighting controls.

 

 

Genzyme is also seeking certification for the building under the U.S. Green Building Council's LEED® (Leadership in Energy and Environmental Design) Green Building Rating SystemTM. The LEED certification system was created to define "green" building by providing a common standard of measurement.

 

This is ARC's sixth major project for Genzyme. ARC started working with Genzyme in 1991 with the design of their Biopharmaceutical Manufacturing Plant along the Charles River in Allston.  Since then, ARC has designed four other projects for Genzyme including the renovation of the Five Mountain Road Laboratory completed in 2000 and the 2001 addition to 45 New York Avenue.